Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

aTYR PHARMA (ATYR) Revenue (2019 - 2025)

Historic Revenue for aTYR PHARMA (ATYR) over the last 6 years, with Q3 2025 value amounting to $190000.0.

  • aTYR PHARMA's Revenue changed N/A to $190000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $190000.0, marking a year-over-year decrease of 1914.89%. This contributed to the annual value of $235000.0 for FY2024, which is 3342.78% down from last year.
  • aTYR PHARMA's Revenue amounted to $190000.0 in Q3 2025.
  • aTYR PHARMA's Revenue's 5-year high stood at $10.4 million during Q4 2022, with a 5-year trough of $190000.0 in Q3 2025.
  • Over the past 4 years, aTYR PHARMA's median Revenue value was $294000.0 (recorded in 2023), while the average stood at $2.8 million.